StrataPATH™ (Precision Indications for Approved Therapies)

NCT05097599 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Business decision and enrollment difficulties

Conditions

Cancer
Advanced Solid Tumor

Interventions

DRUG: lorlatinib
DRUG: encorafenib + binimetinib
DRUG: talazoparib
DRUG: sacituzumab govitecan
DRUG: axitinib
DRUG: Fam-Trastuzumab Deruxtecan-Nxki
DRUG: enfortumab vedotin

Sponsor

Strata Oncology

Collaborators

[object Object]
[object Object]
[object Object]